BSECompany UpdateResults4 Nov 2026
ArisInfra Solutions Ltd
Audio Recording of Investor(s) /Analyst(s) call
ArisInfra Solutions Ltd has made available the audio recording of its earnings call with analysts and investors, held on November 04, 2026, to discuss its Standalone and Consolidated Un-Audited Financial Results for the Quarter and Half-Year ended September 30, 2026.
BSEBoard MeetingResults4 Nov 2026
Rajeswari Infrastructure Ltd
Pursuant to Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that, based on the recommendation and approval of the Board of Directors in its meeting held on 04thNovember, 2026 has, inter alia considered and approved the following:
1.Unaudited Financial Results of the Company for the quarter ended September 30, 2026.
A copy of the Unaudited Standalone Financial Results ....
Rajeswari Infrastructure Ltd has announced its unaudited financial results for the quarter ended September 30, 2026, which were reviewed by the Audit Committee and approved by the Board of Directors. The company has also disclosed that it was admitted into the Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016.
BSEGeneralRegulatory4 Nov 2026
Suzlon Energy Ltd
Rumour verification - Regulation 30(11)
Suzlon Energy Ltd has informed the exchanges that a material price movement was noticed in its scrip on 4th November 2026, but no event or information was found in the mainstream media that could have triggered this movement.
BSECompany UpdateRegulatory4 Nov 2026
Samtex Fashions Ltd-$
Intimation regarding Demand Notice dated 30.10.2026, Recovery Certificate dated 23.10.2026 issued in the case no. TA/446/2022 in the matter of NARCL Vs. SSA International Ltd. & Ors.
Samtex Fashions Ltd has received a Demand Notice and Recovery Certificate from DRT-III in a case related to NARCL vs. SSA International Ltd. The company has been held jointly and severally liable for ₹437,57,28,362.70, along with interest and costs. The company is evaluating the financial impact and legal remedies.
BSECompany Update▲ PositiveResults4 Nov 2026
TVS Motor Company Ltd
Compliance under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
TVS Motor Company Ltd has announced its Q2 FY27 earnings, with the company achieving its highest ever sales volume, revenue, and profits. The sales volume grew 27% to 1.9 million units, revenue grew 44% to INR17,103 crores, and EBITDA grew 47% to INR2,219 crores. The company has also approved a scheme of demerger of its consumer finance and related business undertaking from the company.
BSECompany UpdateMgmt Change4 Nov 2026
Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change4 Nov 2026
Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change4 Nov 2026
Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change4 Nov 2026
Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change4 Nov 2026
Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change4 Nov 2026
Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change4 Nov 2026
Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change4 Nov 2026
Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change4 Nov 2026
Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change4 Nov 2026
Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Dr. Lal Path Labs Ltd. has appointed a Non-Executive Independent Director.
BSECompany UpdateMgmt Change4 Nov 2026
Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change4 Nov 2026
Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change4 Nov 2026
Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change4 Nov 2026
Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change4 Nov 2026
Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.